AbbVie
ABBV
ABBV
1,633 hedge funds and large institutions have $65.6B invested in AbbVie in 2015 Q4 according to their latest regulatory filings, with 155 funds opening new positions, 603 increasing their positions, 673 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.79% less ownership
Funds ownership: 68.76% → 67.97% (-0.79%)
10% less repeat investments, than reductions
Existing positions increased: 603 | Existing positions reduced: 673
20% less call options, than puts
Call options by funds: $739M | Put options by funds: $925M
Holders
1,633
Holding in Top 10
96
Calls
$739M
Puts
$925M
Top Buyers
| 1 | +$255M | |
| 2 | +$208M | |
| 3 | +$176M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$175M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$156M |
Top Sellers
| 1 | -$507M | |
| 2 | -$297M | |
| 3 | -$263M | |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$210M |
| 5 |
Bank of New York Mellon
New York
|
-$204M |